Skip to content
healthcare.dev
Get a free key

Riastap

NDC 63833-892, FIBRINOGEN HUMAN, injection, solution, from CSL Behring GmbH.

Product NDC
63833-892
Status
Listed
Labeler
CSL Behring GmbH
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63833-892 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FIBRINOGEN HUMAN2600 mg/100mL

Pharmacologic classes

Blood Coagulation Factors [CS]; Human Blood Coagulation Factor [EPC]; Increased Coagulation Activity [PE]

Package NDCNDC-11Package
63833-892-51638330892511 VIAL, GLASS in 1 CARTON (63833-892-51) / 100 mL in 1 VIAL, GLASS (63833-892-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63833-892 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63833-892 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63833-892. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.